Search

Merida CSO Deb Kimless Places Peer Reviewed Clinical Article in Journal of Diabetes

Journal of Diabetes & Metabolism, December 11, 2020


Merida's Chief Scientific Officer, Debra Kimless, M.D., recently co-authored and published an article in the Journal of Diabetes & Metabolism entitled "The Effects of Cannabidiol-Based Sublingual Tablets on Diabetic Neuropathic Pain."


After a 21-day study, research found that patients with chronic diabetic neuropathic pain who took CBD sublingual tablets three times a day reported significant reduction in pain as well as signifiancant improvement in sleep quality and a reduction in anxiety and without any adverse drug reactions in patients.


To read and download the full article, click here.

CONTACT US

MERIDA CAPITAL HOLDINGS

641 LEXINGTON AVENUE

SUITE 1801

NEW YORK, NY  10022

 

 

INFO@MERIDACAP.COM

@MeridaCap

© 2020 by Rapid Fig